404 related articles for article (PubMed ID: 23729166)
1. Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.
Pimentel CB; Lapane KL; Briesacher BA
Drugs Aging; 2013 Sep; 30(9):701-20. PubMed ID: 23729166
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. Medicare Part D and quality of prescription medication use in older adults.
Lau DT; Briesacher BA; Touchette DR; Stubbings J; Ng JH
Drugs Aging; 2011 Oct; 28(10):797-807. PubMed ID: 21970307
[TBL] [Abstract][Full Text] [Related]
4. Medicare Part D's effect on the under- and overuse of medications: a systematic review.
Polinski JM; Donohue JM; Kilabuk E; Shrank WH
J Am Geriatr Soc; 2011 Oct; 59(10):1922-33. PubMed ID: 21806563
[TBL] [Abstract][Full Text] [Related]
5. Adequacy of Prescription Drug Coverage in Long-term Care.
Briesacher B; Oliveri-Mui B; Chhabra B; Koethe B
Med Care; 2020 May; 58(5):427-432. PubMed ID: 31985585
[TBL] [Abstract][Full Text] [Related]
6. Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.
Park YJ; Martin EG
Health Serv Res; 2017 Oct; 52(5):1685-1728. PubMed ID: 27480577
[TBL] [Abstract][Full Text] [Related]
7. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
Safran DG; Strollo MK; Guterman S; Li A; Rogers WH; Neuman P
J Gen Intern Med; 2010 Jan; 25(1):10-7. PubMed ID: 19882193
[TBL] [Abstract][Full Text] [Related]
8. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Medication Reviews in Long-term Care Facilities: History of Process Implementation and 2015 Results.
O'Shea TE; Zarowitz BJ; Erwin WG
J Manag Care Spec Pharm; 2017 Jan; 23(1):22-26. PubMed ID: 28025922
[TBL] [Abstract][Full Text] [Related]
10. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
Bazalo G; Weiss RC
Consult Pharm; 2012 Apr; 27(4):269-73. PubMed ID: 22498986
[TBL] [Abstract][Full Text] [Related]
11. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
12. Measurement of unused medication in Medicare Part D residents in skilled nursing facilities.
Bazalo G; Weiss RC
Consult Pharm; 2011 Sep; 26(9):647-56. PubMed ID: 21896471
[TBL] [Abstract][Full Text] [Related]
13. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
14. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
[TBL] [Abstract][Full Text] [Related]
16. The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings.
Neuenschwander JF; Silverstein AR; Teigland CL; Kumar S; Zeng EY; Agiro AT; Pottorf WJ; Peacock WF
Adv Ther; 2023 Mar; 40(3):1204-1223. PubMed ID: 36652174
[TBL] [Abstract][Full Text] [Related]
17. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
18. The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes.
Choi YJ; Jia H; Gross T; Weinger K; Stone PW; Smaldone AM
Diabetes Care; 2017 Apr; 40(4):502-508. PubMed ID: 27803119
[TBL] [Abstract][Full Text] [Related]
19. Impact of U.S. federal and state generic drug policies on drug use, spending, and patient outcomes: A systematic review.
Mishuk AU; Fasina I; Qian J
Res Social Adm Pharm; 2020 Jun; 16(6):736-745. PubMed ID: 31445986
[TBL] [Abstract][Full Text] [Related]
20. Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.
Polinski JM; Brookhart MA; Glynn RJ; Schneeweiss S
J Clin Psychopharmacol; 2012 Feb; 32(1):3-10. PubMed ID: 22198455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
